These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance. IJzermans T; van der Meijden W; Hoeks M; Huigen M; Rennings A; Nijenhuis T Am J Kidney Dis; 2023 Apr; 81(4):493-496. PubMed ID: 36223829 [TBL] [Abstract][Full Text] [Related]
23. Hyperdibasicaminoaciduria and hyperammonemia in familial protein intolerance. Kato T; Tanaka E; Horisawa S Am J Dis Child; 1976 Dec; 130(12):1340-4. PubMed ID: 998577 [TBL] [Abstract][Full Text] [Related]
24. Reduced nitric oxide production by L-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation. Kayanoki Y; Kawata S; Yamasaki E; Kiso S; Inoue S; Tamura S; Taniguchi N; Matsuzawa Y Metabolism; 1999 Sep; 48(9):1136-40. PubMed ID: 10484053 [TBL] [Abstract][Full Text] [Related]
28. Urinary purines and pyrimidines in patients with hyperammonemia of various origins. Van Gennip AH; Van Bree-Blom EJ; Grift J; DeBree PK; Wadman SK Clin Chim Acta; 1980 Jun; 104(2):227-39. PubMed ID: 6771064 [TBL] [Abstract][Full Text] [Related]
29. [Lysinuric protein intolerance]. Behbehani AW; Gahr M; Schröter W Monatsschr Kinderheilkd; 1983 Nov; 131(11):784-7. PubMed ID: 6420670 [TBL] [Abstract][Full Text] [Related]
30. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608 [TBL] [Abstract][Full Text] [Related]
31. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance. Simell O; Sipilä I; Rajantie J; Valle DL; Brusilow SW Pediatr Res; 1986 Nov; 20(11):1117-21. PubMed ID: 3099249 [TBL] [Abstract][Full Text] [Related]
32. Renal handling of diamino acids in lysinuric protein intolerance. Simell O; Perheentupa J J Clin Invest; 1974 Jul; 54(1):9-17. PubMed ID: 4600043 [TBL] [Abstract][Full Text] [Related]
33. Role of argininosuccinate synthetase in the regulation of urea synthesis in the rat and argininosuccinate synthetase-associated metabolic disorder in man. Saheki T; Tsuda M; Takada S; Kusumi K; Katsunuma T Adv Enzyme Regul; 1980; 18():221-38. PubMed ID: 7446299 [No Abstract] [Full Text] [Related]
34. Carnitine deficiency and L-carnitine supplementation in lysinuric protein intolerance. Tanner LM; Näntö-Salonen K; Rashed MS; Kotilainen S; Aalto M; Venetoklis J; Niinikoski H; Huoponen K; Simell O Metabolism; 2008 Apr; 57(4):549-54. PubMed ID: 18328359 [TBL] [Abstract][Full Text] [Related]
36. Studies on liver argininosuccinate synthetase in a patient with citrullinemia and in normal subjects. Matsuda Y; Tsuji A; Katunuma N; Hayashi M; Takahashi Y J Biochem; 1979 Jan; 85(1):191-5. PubMed ID: 762042 [No Abstract] [Full Text] [Related]